Logos Global Management LP's Net Worth
$20 Million
Who is Logos Global Management LP?
Logos Global Management LP has an estimated net worth of $20 Million. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., Verve Therapeutics, Inc., and Novus Therapeutics, Inc..
SEC CIK
Logos Global Management LP's CIK is 0001792126
Past Insider Trading and Trends
2020 was Logos Global Management LP's most active year for acquiring shares with 9 total transactions. Logos Global Management LP's most active month to acquire stocks was the month of September. 2020 was Logos Global Management LP's most active year for disposing of shares, totalling 3 transactions. Logos Global Management LP's most active month to dispose stocks was the month of September. 2020 saw Logos Global Management LP paying a total of $15,641,713.69 for 1,596,432 shares, this is the most they've acquired in one year. In 2020 Logos Global Management LP cashed out on 2,681,058 shares for a total of $345,558.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.5M |
$19.00 |
—
| 1.5M |
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $10.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 813.26K |
$19.00 | $7,030,000.00 | 813.26K |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Novus Therapeutics, Inc. (ELDN) Snapshot price: $1.9834
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +54.53% | 79.07K |
$26.04 | $1,996,154.91 | 224.07K |
Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||